We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Abbott Labs | LSE:ABT | London | Ordinary Share | COM STK NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 53.50 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMABT
RNS Number : 1449L
Abbott Laboratories
28 September 2016
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM Details of the person discharging managerial 1. responsibilities/person closely associated a) Name Daniel Gesua Sive Salvadori ------------------------ -------------------------------------- 2. Reason for the notification Senior Vice President, Established a) Position / status Pharmaceuticals, Latin America ------------------------ -------------------------------------- Initial notification b) / amendment Initial Notification ------------------------ -------------------------------------- Details of the issuer, emission allowance market participant, auction platform, auctioneer 3. or auction monitor a) Name Abbott Laboratories ------------------------ ------------------------- ----------- b) LEI HQD377W2YR662HK5JX27 ------------------------ ------------------------- ----------- Details of the transaction(s) Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where 4. transactions have been conducted Description of the financial instrument, Common Shares without par a) type of instrument value ------------------------ -------------------------------------- Identification code US0028241000 ------------------------ -------------------------------------- Nature of the Disposal of shares in payment b) transaction of tax liability ------------------------ -------------------------------------- Price(s) Volume(s) ------------------------ ------------------------- ----------- c) USD 42.19 2,001 ------------------------ ----------- Aggregated information -------------------------------------- - Aggregated volume -------------------------------------- d) - Price ------------------------ -------------------------------------- Date of the e) transaction 2016-09-26 ------------------------ -------------------------------------- Place of the f) transaction New York Stock Exchange (XNYS) ------------------------ -------------------------------------- Details of the transaction(s) Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where 5 transactions have been conducted Description of the financial instrument, Common Shares without par a) type of instrument value ------------------------ -------------------------------------- Identification code US0028241000 ------------------------ -------------------------------------- Nature of the b) transaction Sale of ABT Securities ------------------------ -------------------------------------- Price(s) Volume(s) ------------------------ ------------------------- ----------- c) USD 41.711 815 ------------------------ ----------- Aggregated information ---------------- - Aggregated volume ---------------- d) - Price --------------------------------------------------- ----------- Date of the e) transaction 2016-09-26 ------------------------ -------------------------------------- Place of the f) transaction New York Stock Exchange (XNYS) ------------------------ --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAFNPAFSKEAF
(END) Dow Jones Newswires
September 29, 2016 02:00 ET (06:00 GMT)
1 Year Abbott Labs Chart |
1 Month Abbott Labs Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions